AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Celldex Therapeutics, Inc. Director's Dealing 2025

Jun 9, 2025

Director's Dealing

Opens in your device viewer

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2025-06-05

Reporting Person: PENNER HARRY JR (N/A)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-05	Non-Qualified Stock Option (right to buy)	$19.53	A	16500	Acquired	2035-06-05	Common Stock (16500)	Direct

F1: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.